Publication decisions

The editor of the journal “Current issues in pharmacy and medicine: science and practice” is responsible for deciding what articles submitted to the journal should be published. The validation of the work in question and its importance to researchers and readers must always drive such decisions. The editor must be guided by the policies of the journal’s editorial board and constrained by such legal requirements otherwise libel, copyright infringement, and plagiarism will be a force. The editor may confer with other editors or reviewers in making this decision.

Fair play

The editor of the journal «Current issues in pharmacy and medicine: science and practice» evaluates manuscripts for their intellectual content without regard to race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors.

Confidentiality

The editor of the journal “Current issues in pharmacy and medicine: science and practice” and any editorial staff must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.

Disclosure and conflicts of interest

Unpublished materials disclosed in a submitted manuscript must not be used in an editor’s own research without the express written consent of the author. Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage.

Editors should recuse themselves from considering manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or (possibly) institutions connected with the papers.

Editors should require all contributors to disclose relevant competing interests and publish corrections if competing interests are revealed after publication. If needed, other appropriate action should be taken, such as the publication of a retraction or expression of concern. It should be ensured that the peer-review process for sponsored supplements is the same as that used for the main journal. Items in sponsored supplements should be accepted solely on the basis of academic merit and interest to readers and not be influenced by commercial considerations.

Non-peer-reviewed sections of their journal should be clearly identified.

Involvement and cooperation in investigations

The editor of the journal “Current issues in pharmacy and medicine: science and practice” should take reasonably responsive measures when ethical complaints have been presented concerning a submitted manuscript or published paper, in conjunction with the publisher (or society).

Such measures will generally include contacting the author of the manuscript or paper and giving due consideration of the respective complaint or claims made, but may also include further communications to the relevant institutions and research bodies, and if the complaint is upheld, the publication of a correction, retraction, expression of concern, or other note, as may be relevant. Every reported act of unethical publishing behavior must be looked into, even if it is discovered years after publication.